Moclavin (Amoxicillin, Clavulanic Acid)

Amoxicillin/Clavulanic Acid, the active ingredient in Moclavin, is a penicillin antibiotic with beta‑lactamase inhibitor presented as an oral tablet for oral use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Moclavin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclavin, a penicillin‑type antibacterial, is indicated for infections caused by susceptible bacteria in several organ systems.

- Acute bacterial sinusitis: reduces infection and alleviates sinus pressure and discharge. - Acute otitis media: eradicates the causative pathogens and improves ear pain. - Community‑acquired pneumonia: clears pulmonary infection and improves breathing function. - Uncomplicated urinary tract infections: eliminates uropathogens and resolves dysuria. - Skin and soft‑tissue infections: treats cellulitis and other superficial bacterial skin conditions.

Moclavin may cause a range of adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Nausea: mild stomach upset often occurring after dosing. - Diarrhea: loose stools that may be watery. - Rash: skin redness or mild itching. - Headache: transient head discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty and swelling. - Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain. - Hepatic injury: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Neutropenia: marked reduction in white blood cells increasing infection risk.

Before prescribing Moclavin, clinicians should consider several safety factors.

- Assess renal function: adjust dose in patients with renal impairment. - Monitor for allergic reactions: discontinue immediately if severe rash or anaphylaxis occurs. - Use with caution in hepatic disease: observe liver function tests. - Avoid in patients with known hypersensitivity to penicillins or beta‑lactamase inhibitors. - Pregnancy category B: generally safe but should be used only when clearly needed. - Store below 25°C: keep in the original pack, protect from moisture.

Moclavin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Probenecid: increases amoxicillin plasma levels, raising toxicity risk. - Methotrexate: may enhance methotrexate toxicity. - Oral contraceptives: may reduce hormonal efficacy, increasing pregnancy risk. - Warfarin: can potentiate anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Allopurinol: heightened risk of skin rash. - Ciprofloxacin: increased seizure risk in susceptible individuals. - Clarithromycin: may augment gastrointestinal side effects.